Skip to main content

Greenland Capital Management LP

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 1896430 NEW YORK, NY

Position in MLYS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$809,400
-$748,275 QoQ
Shares Held
30,000
-47.8% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#122
of 223 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MLYS Over Time

Shares Held

Position Value (USD)

Derivatives in MLYS

reported options exposure · as of Mar 31, 2026
CallValue
$704,340
CallShares
26,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Greenland Capital Management LP holds $9,138,618 across 8 Biotechnology names. MLYS ranks #6 (8.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 MLYS
Mineralys Therapeutics, Inc.
This page
30,000 $809,400

All Filings in MLYS

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $809,400 30,000
2026-03-31 $704,340 26,000
2026-03-31 $1,557,675 57,500
2025-12-31 $2,504,010 69,000
2025-09-30 $4,013,945 105,853
2025-06-30 $135,300 10,000
2025-03-31 $317,600 20,000